Clinical Trial Update: Impact of Remimazolam on Prognosis After Bladder Cancer Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether remimazolam used during bladder cancer surgery influences prognosis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Peking University First Hospital | Conditions: Benzodiazepines, Bladder Cancer | Phase 4 | Status: RECRUITING